Advertisement
EMR vs IPAC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMR is a Hold and IPAC is a Hold.
EMR in upward trend: 10-day moving average moved above 50-day moving average on September 29, 2026
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on EMR as a result. In 55 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for EMR just turned positive on October 27, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in 28 of 44 cases over the following month. The odds of a continued upward trend are 64%.
Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 217 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 150 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 17 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 40%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 30 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 43 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.543) is normal, around the industry mean (4.069). P/E Ratio (36.157) is within average values for comparable stocks, (37.908). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.013) settles around the average of (0.031) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
IPAC in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 14, 2026
IPAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 38 cases where IPAC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPAC advanced for three days, in 251 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 60 cases where IPAC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IPAC as a result. In 66 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for IPAC turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 33 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
IPAC moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IPAC crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for IPAC entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
EMR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 18 | |
SMR RATING 1..100 | 62 | |
PRICE GROWTH RATING 1..100 | 30 | |
P/E GROWTH RATING 1..100 | 43 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EMR | IPAC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 40% | N/A |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 75% |
| Momentum ODDS (%) | 2 days ago 60% | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 76% |
| TrendMonth ODDS (%) | 2 days ago 56% | 2 days ago 72% |
| Advances ODDS (%) | 6 days ago 63% | 8 days ago 79% |
| Declines ODDS (%) | 15 days ago 56% | 2 days ago 74% |
| BollingerBands ODDS (%) | 2 days ago 57% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 68% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EMR’s FA Score shows that 2 FA rating(s) are green while .
- EMR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EMR’s TA Score shows that 5 TA indicator(s) are bullish.
- EMR’s TA Score: 5 bullish, 4 bearish.
Price Growth
EMR (@Industrial Machinery) experienced а +2.63% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was +1.91%. For the same industry, the average monthly price growth was -12.24%, and the average quarterly price growth was -18.58%.
Reported Earning Dates
EMR is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Industrial Machinery (+1.91% weekly)The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
Advertisement
IPAC and
Correlation & Price change
A.I.dvisor indicates that over the last year, IPAC has been closely correlated with MFG. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IPAC jumps, then MFG could also see price increases.
| Ticker / NAME | Correlation To IPAC | 1D Price Change % | ||
|---|---|---|---|---|
| IPAC | 100% | -0.19% | ||
| MFG - IPAC | 70% Closely correlated | -0.52% | ||
| ING - IPAC | 67% Closely correlated | -0.25% | ||
| BHP - IPAC | 65% Loosely correlated | +1.15% | ||
| RIO - IPAC | 62% Loosely correlated | +1.03% | ||
| EMR - IPAC | 60% Loosely correlated | +0.62% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EQTY | 29.70 | 0.13 | +0.42% |
| Kovitz Core Equity ETF (EQTY) | |||
| CBIL | 24.90 | N/A | N/A |
| Corgi 3-12 Month T-Bill ETF (CBIL) | |||
| XLVX | 38.45 | -0.07 | -0.18% |
| Corgi U.S. Healthcare 2x Daily ETF (XLVX) | |||
| VEGA | 51.95 | -0.15 | -0.30% |
| AdvisorShares STAR Global Buy-Write ETF (VEGA) | |||
| ARDC | 11.68 | -0.04 | -0.34% |
| Ares Dynamic Credit Allocation Fund | |||